Buying a pharmacy in 2026: price, procedures, and why almost no one does it without help

Buying a pharmacy is not like buying a commercial property. It’s not enough to have the money, find the location, and sign in front of a notary. The process involves specific legal requirements, negotiations with the owner, administrative procedures with the autonomous communities, and an economic valuation that, if not done correctly, can cost you dearly in the most literal sense.

The market for transferring pharmacies in Spain has been one of the most regulated sectors for years, while also being one of the most active in terms of buying and selling operations. And in 2026, the trend continues: there are pharmacies coming onto the market, interested buyers, and a process that, without the right guidance, can turn into a bureaucratic nightmare. This is why many professionals turn to Covefa, a consultancy specialised in the buying, selling, and valuation of pharmacies.

How much does a pharmacy cost in 2026

The million-dollar question, literally. The price of a pharmacy in Spain depends on several factors that have nothing to do with the square metres of the premises or how attractive the shop window is.

The central element of the valuation is the turnover, specifically the annual gross sales. From there, multipliers are applied that vary according to the autonomous community, location, profit margin, age of the business, and whether the premises are owned or rented, among other factors.

As a rough guide:

• Small pharmacies (turnover below 500,000 euros per year): the price can range from 200,000 to 400,000 euros.
• Medium pharmacies (between 500,000 and 1.5 million euros in turnover): the range usually falls between 400,000 and 1.2 million euros.
• Large or well-located pharmacies (more than 1.5 million euros): transactions can exceed 2 million, and in prime areas of large cities, much more.

That said, these figures are indicative. The actual price of a pharmacy is negotiated on a case-by-case basis, and this is where a professional valuation makes the difference between paying a fair price and overpaying.

The multipliers and how they influence the final price

Historically, multipliers of between 1 and 1.5 times the annual turnover were considered standard references. But this criterion has evolved over time. Nowadays, the following are also taken into account:

• The actual EBITDA of the business (what remains after operating expenses)
• The lease contract of the premises, if not owned by the pharmacist
• The public prescription volume versus over-the-counter sales, as it directly affects income stability
• The area of influence, i.e., the assigned population and demographic profile
• The nearby competition and the possibilities of opening new pharmacies in the area

All of this makes the valuation of a pharmacy a technical exercise that goes far beyond just looking at the bank statement from the last fiscal year.

The legal process of buying and selling: more paperwork than it seems

Once the price is agreed upon, the administrative process is the next challenge. And it’s not a minor one. In Spain, the ownership of a pharmacy is regulated by each autonomous community, meaning that the procedures vary depending on where the pharmacy is located.

In general terms, the process includes:

1. Verification of the buyer's capacity: in Spain, only registered pharmacists can be owners of a pharmacy. No companies with shareholders outside the profession.
2. Authorization of transfer: the autonomous community must approve the operation before it becomes effective. Here, the timeframes can vary greatly, from weeks to months.
3. Communication to the College of Pharmacists: the corresponding regional college must be informed and, in many cases, actively participates in the process.
4. Purchase contract and notarial deed: the operation must be formalised before a notary with all documentation in order.
5. Change of ownership in the Health Registry: essential for the buyer to operate legally.

What can complicate (and delay) the operation

The most common issues in these operations relate to incomplete documentation from the seller, discrepancies in stock valuation, conditions of the lease contract for the premises, or problems with administrative authorization. Each of these points can halt an operation for weeks.

This is why having specialised advice from the start is not a luxury; it’s a practical necessity. The difference between managing this with a generic advisor or with someone who truly understands the pharmaceutical sector can be, at best, weeks of processing time saved. At worst, a transaction that never gets completed.

Why it’s advisable not to improvise in these types of operations

The pharmacy market in Spain is not opaque, but it is also not transparent. There is no portal where you can see all the pharmacies for sale with their prices and conditions, like Idealista. Transactions largely occur through specialised intermediaries, industry contacts, or consultancies with access to a portfolio of active operations.

Here are three clear advantages of working with a specialised consultancy:

• Access to operations not in the open market: many sellers prefer discretion, especially while the pharmacy is still operational.
• Objective valuation: whether you are a buyer or a seller, having a technical and independent valuation protects you from overpricing or undervaluing the business.
• Support throughout the process: from initial negotiation to change of ownership, including economic due diligence and managing documentation with the administration.

This is especially relevant for pharmacists buying for the first time. They know the business from the inside, but the acquisition process has its own rules, and making mistakes in the valuation phase or in reviewing contracts can have consequences that last for years.

Financing: how a pharmacy is usually paid for

Few people have 600,000 euros available in liquidity to close a deal outright. The good news is that most banks have specific products for financing pharmacies, as it is a business with predictable income and a low closure rate.

Typical conditions include:

• Financing of up to 70-80% of the purchase price
• Amortisation periods of between 10 and 15 years
• Initial grace periods in some cases
• Guarantees based on the pharmacy itself as an asset

The key is to present a solid dossier to the bank: with the pharmacy’s valuation, historical turnover, business plan, and, if possible, a due diligence report that certifies the real situation of the business. The more complete the documentation, the better financing conditions can be obtained.

The timing of the purchase also influences

The market is not the same at all times or in all areas. In 2026, there is an observed increase in transactions linked to the retirement of pharmacists from the generation that opened or bought their pharmacies in the 1980s and 1990s. This creates a larger supply, which theoretically benefits the buyer. But there are also more well-informed buyers, which balances the scales.

The advice given by industry specialists is always the same: if a good opportunity arises, do not improvise. Surround yourself with professionals who know the market, the real prices, and the administrative procedures; this is the difference between closing a deal under optimal conditions or dragging problems for years.